NSE ScannerComparison · NSE · data 2026-10-30
Laurus Labs Ltd. vs Zydus Lifesciences Limited
In plain words
Size: Laurus Labs Ltd. is about 1 times the market value of Zydus Lifesciences Limited.
Valuation (P/E): Laurus Labs Ltd. 97.1 vs Zydus Lifesciences Limited 27.8.
Profit growth over 3 years: Zydus Lifesciences Limited 37% a year vs Laurus Labs Ltd. 4% a year.
Differences in the numbers, not a recommendation of either stock.
Side by side
| LAURUSLABS | ZYDUSLIFE | |
|---|---|---|
| Price | ₹2,405.5 | ₹1,245.5 |
| Market cap | ₹1,21,300 cr | ₹1,18,304 cr |
| P/E | 97.1 | 27.8 |
| P/B | 21.5 | — |
| ROE | 18.2% | 19.7% |
| ROCE | 20.5% | 17.8% |
| Debt / equity | 0.48 | 0.46 |
| Operating margin | 24.1% | 18.6% |
| Dividend yield | 0.09% | 0.08% |
| Sales growth, 3 years (yearly) | 4.1% | 16.6% |
| Profit growth, 3 years (yearly) | 4.0% | 37.0% |
| 1-year return | 149.8% | 24.1% |
| Revenue, last 12 months | ₹7,823 cr | ₹28,592 cr |
| Net profit, last 12 months | ₹1,340 cr | ₹4,513 cr |
| Latest quarter | Jun 2024 | Mar 2024 |
| Quarter net profit | ₹13 cr | ₹64 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 27.49% | 75.01% |
| Health check | Average (6/10) | Strong (7.9/10) |
Common questions
Which has a higher P/E, Laurus Labs Ltd. or Zydus Lifesciences Limited?
Laurus Labs Ltd. trades at the higher P/E (97.1 against 27.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Zydus Lifesciences Limited (19.7% against 18.2%).
Which carries more debt?
Laurus Labs Ltd. has the higher debt-to-equity ratio (0.48 against 0.46).